AON community oncology practices across the nation offering groundbreaking immunotherapy to expand treatment options for hard ...

PFAS, found in everyday items, may weaken babies’ immune cells and immune systems before birth and during infancy.

Among the patients treated was 49-year-old lady from Odisha, diagnosed with acute B-cell lymphoblastic leukemia. After receiving the customized therapy, she showed significant recovery and was ...

Hodgkin's lymphoma market size is expected to increase during the forecast period (2025–2034) owing to increasing incidence, advancements in ...

Study is the first to identify specific infant immune cell changes resulting from prenatal PFAS exposure, patterns associated with weaker vaccine responses, increased allergy risk, and potential ...

Glofitamab is a bispecific CD20-directed CD3 T-cell engager approved under the brand name Columvi ® for the treatment of adults with R/R DLBCL, not otherwise specified or large B-cell lymphoma arising ...

Confused about hair transplant vs hair restoration? Learn the key differences, benefits, and which option might be right for ...

Ever notice how some people seem to build muscle eating whatever they want, while you’re over here measuring every ounce […] ...

Appointments of new CEO, CFO, and seasoned business development leaders with proven track records of executing strategic transactions will position the Company to drive shareholder value and advance p ...